FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: We used the fkrp morphant model of FKRP-associated dystroglycanopathy [39, 72] to address unanswered questions regarding NAD+ regulation of the ECM in a secondary dystroglycanopathy.